Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

32.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 105.50
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 106.84m
  • Volume: 146,816
  • Market Cap: £34.19m
  • RiskGrade: 594

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 29.2  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (1.68) (2.50)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 n/a (5.00) (5.00)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Management Changes 10-Jul-2024 07:00 RNS
Positive Data from SDC-1801 Phase 1 Clinical Trial 01-Jul-2024 07:00 RNS
Appointment of Sole Broker 30-May-2024 07:00 RNS

Sareum Holdings ShareCast News

Sareum announces positive results from kinase in... 01-Jul-2024 ShareCast
Sareum allowed European patent for primary kinas... 15-Mar-2024 ShareCast
Sareum reports positive progress in psoriasis pr... 15-Feb-2024 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 32.00p
Change Today 0.50p
% Change 1.59 %
52 Week High 105.50
52 Week Low 10.25
Volume 146,816
Shares Issued 106.84m
Market Cap £34.19m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.43% below the market average51.43% below the market average51.43% below the market average51.43% below the market average51.43% below the market average
13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average
Price Trend
90.72% below the market average90.72% below the market average90.72% below the market average90.72% below the market average90.72% below the market average
76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:30 1,000 @ 31.20p
16:29 100 @ 33.00p
16:28 100 @ 33.00p
16:26 3,036 @ 32.80p
15:30 4,754 @ 31.50p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page